Lauren Zuffante practices intellectual property law with an emphasis on complex patent and Hatch-Waxman litigation in the pharmaceutical and chemical arts. While in law school, Lauren served as President of the Intellectual Property Law Association and as a member of the Appellate Advocacy Moot Court Board.
Endo Pharmaceuticals Inc. v. Depomed, Inc., IPR2014-00652, Final Written Decision
Lauren helped obtained a Final Written Decision of invalidity in an inter partes review of U.S. Patent No. 6,723,340 owned by Depomed, Inc. on behalf of clients Endo Pharmaceuticals Inc. and Grünenthal GmbH. Despite previous invalidity challenges of the ’340 patent and related patents by others, the Fitzpatrick team was able to show that the asserted claims of the ’340 patent are unpatentable for obviousness.